Fol. Biol. 2009, 55, 35-40
https://doi.org/10.14712/fb2009055020035
Association of Paraoxonase 55 and 192 Gene Polymorphisms on Serum Homocysteine Concentrations in Preeclampsia
References
1. , S., Gan, K. N., Mody, M., La Du, B. N. (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598-608.
2. , B., Yilmaz, H., Karaali, Z., Isbir, T. (2004) Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem. Funct. 22, 163-168.
<https://doi.org/10.1002/cbf.1070>
3. , B., Yilmaz, H., Ergen, H. A., Karaali, Z. E., Isbir, T. (2005) Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus. Physiol. Res. 54, 287-293.
<https://doi.org/10.33549/physiolres.930530>
4. , M., Murtomäki, S., Syvänne, M., Pahlman, R., Tahvanainen, E., Jauhiainen, M., Frick, M. H., Ehnholm, C. (1996) The Gln Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J. Clin. Invest. 98, 883-885.
<https://doi.org/10.1172/JCI118869>
5. , I., Sirin, A., Agaçhan, B., Emre, S., Sadikoglu, B., Yilmaz, H., Sucu, A., Isbir, T. (2007) Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Cell Biochem. Funct. 25, 159-165.
<https://doi.org/10.1002/cbf.1288>
6. , K., Ueland, P. M., Harsem, N. K., Karlsen, A., Blomhoff, R., Staff, A. C. (2007) Homocysteine, cysteine, and related metabolites in maternal and fetal plasma in preeclampsia. Pediatr. Res. 62, 319-324.
<https://doi.org/10.1203/PDR.0b013e318123fba2>
7. , G. A., van Geijn, H. P. (1996) Endothelial dysfunction in preeclampsia. Part II. Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives. J. Perinat. Med. 24, 119-139.
<https://doi.org/10.1515/jpme.1996.24.2.119>
8. , H. W., Wyte, C. M., La Du, B. N. (1983) The human serum paraoxonase/arylesterase polymorphism. Identification of phenotypes by their response to salts. Am. J. Hum. Genet. 35, 214-227.
9. , A., Philipp, M., Hess, K., Katz, N., Tillmanns, H., Haberbosch, W. (2000) The paraoxonase Leu Met54 and Gln Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis 152, 421-431.
<https://doi.org/10.1016/S0021-9150(99)00489-X>
10. , E., Casals, E., Deulofeu, R., Cararach, V., Alonso, P. L., Fortuny, A. (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am. J. Obstet. Gynecol. 178, 1072-1076.
<https://doi.org/10.1016/S0002-9378(98)70550-2>
11. , E. (2000) Lipidmediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 92, 63-66.
<https://doi.org/10.1016/S0301-2115(00)00427-9>
12. , S. M., Blanc, H., Poirier, O., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J. M., Cambien, F. (1996) The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis 126, 299-304.
<https://doi.org/10.1016/0021-9150(96)05917-5>
13. , V. A., Wallace, J. M., Alexander, H. D., Gilmore, W. S., Bradbury, I., Ward, M., Scott, J. M., Mcfaul, P., McNulty, H. (2005) Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin. Chem. 51, 629-634.
<https://doi.org/10.1373/clinchem.2004.032698>
14. , C. A. (1999) Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med. 222, 222-235.
<https://doi.org/10.1046/j.1525-1373.1999.d01-139.x>
15. , R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., Furlong, C. E. (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3, 73-76.
<https://doi.org/10.1038/ng0193-73>
16. , H., Ambrosius, W. T., Pratt, H. (2001) Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 491, 35-39.
<https://doi.org/10.1016/S0014-5793(01)02143-3>
17. , H. (2002) Homocysteine is a protein amino acid in humans: Implications for homocysteinelinked disease. J. Biol. Chem. 277, 30425-30428.
<https://doi.org/10.1074/jbc.C200267200>
18. , Y. J., Park, H. S., Park, M. H., Suh, S. H., Pang, M., G. (2005) Oxidative stress -related gene polymorphism and the risk of preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 119, 42-46.
<https://doi.org/10.1016/j.ejogrb.2004.06.009>
19. , S., Aydin, S., Gursu, M. F., Ozcan, Z. (2004) Changes of serum paraoxonase (an HDL cholesterolassociated lipo philic antioxidant) and arylesterase activities in severe preeclamptic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 114, 177-181.
<https://doi.org/10.1016/j.ejogrb.2003.10.023>
20. , M., Skorupski, W., Cieslinski, A., Sokolowska, J., Trzeciak, W. H., Jakubowski, H. (2004) Determinants of homocysteine -thiolactonase activity of the paraoxonase1 (PON1) protein in humans. Cell Mol. Biol. 50, 885-893.
21. , D. A., Gaunt, T. R., Hinks, L. J., Smith, G. D., Timpson, N., Day, I. A., M., Ebrahim, S. (2006) The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women’s Heart and Health cohort study. Paediatr. Perinat. Epidemiol. 20, 244-250.
<https://doi.org/10.1111/j.1365-3016.2006.00716.x>
22. , B., Durrington, P. N., Mackness, M. I. (1998) Human serum paraoxonase. Gen. Pharmac. 31, 329-336.
<https://doi.org/10.1016/S0306-3623(98)00028-7>
23. , L. E., Latthe, P. M., Villar, J., Kilby, M. D., Carroli, G., Khan, K. S. (2005) Mapping the theories of preeclampsia: the role of homocysteine. Obstet. Gynecol. 105, 411-425.
<https://doi.org/10.1097/01.AOG.0000151117.52952.b6>
24. , S. A., Dykes, D. D., Polesky, H. S. (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16, 1215.
<https://doi.org/10.1093/nar/16.3.1215>
25. , M., Perico, N., Remuzzi, G. (2005) Mechanisms of disease: pre eclampsia. Nat. Clin. Pract. Nephrol. 1, 98-114.
<https://doi.org/10.1038/ncpneph0035>
26. , J. M., Gammill, H. S. (2005) Preeclampsia: recent insights. Hypertension 46, 1243-1249.
<https://doi.org/10.1161/01.HYP.0000188408.49896.c5>
27. , E., Safak, O., Dirican, M., Uncu, G. (2004) Oxidizability of apolipoprotein B containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia. Clin. Biochem. 37, 990-996.
<https://doi.org/10.1016/j.clinbiochem.2004.06.013>
28. , H., Schmidt, R., Niederkorn, K., Gradert, A., Schumacher, M., Watzinger, N., Hartung, H. P., Kostner, G. M. (1998) Paraoxonase PON1 polymorphism Leu Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29, 2043-2048.
<https://doi.org/10.1161/01.STR.29.10.2043>
29. , M., Marian, A. L. (1995) A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary heart disease. J. Clin. Invest. 96, 3005-3008.
<https://doi.org/10.1172/JCI118373>
30. , J. B., Vermaak, W. H. J., Bissbort, S. (1991) Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565, 441-446.
<https://doi.org/10.1016/0378-4347(91)80407-4>
31. , H., Benian, A., Madazli, R., Topcuoglu, M. A., Aydin, S., Albayrak, M. (2005) Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol. Obstet. Invest. 60, 195-200.
<https://doi.org/10.1159/000087205>
32. , H., Unlucerci, Y., Gurdol, F., Isbilen, E., Isbir, T. (2004) Association of pre-eclampsia with hyperhomocysteinaemia and methylene-tetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust. N. Z. J. Obstet. Gynaecol. 44, 423-427.
<https://doi.org/10.1111/j.1479-828X.2004.00283.x>
